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Volume 53, Number 1 Abstracts 253Conclusions: Thirty-day VTE risk can be quantified in the outpatient
surgery population using a simple risk-scoringmodel. Aggressive chemopro-
phylaxis may be considered in patients with higher risk. However, further
research is necessary to examine the risks, benefits, and cost of chemopro-
phylaxis for outpatient surgery.
Table.
Risk factor
Adjusted odds ratio
(95% CI) P value
Male gender 1.04 (0.77-1.40) .819
General anesthesia 1.38 (0.95-2.00) .091
Arthroscopic surgery 4.87 (2.88-8.21) .001
Abdominal laparoscopy 1.15 (0.72-1.82) .555
Current pregnancy 8.91 (1.11-71.24) .035
Active cancer 5.38 (2.33-12.41) .001
Congestive heart failure 3.73 (0.43-32.21) .231
Chronic obstructive
pulmonary disease
1.24 (0.49-3.13) .648
Diabetes requiring medication 0.86 (0.51-1.45) .567
Central vascular disease 1.40 (0.84-2.33) .192
Peripheral vascular disease 0.73 (0.17-3.14) .642
Current smoker 0.99 (0.67-1.46) .940
Renal failure on dialysis 0.70 (0.16-3.09) .636
Prior operation within 30 days 1.09 (0.40-2.99) .872
Invasive venous procedure 13.42 (9.56-18.84) .001
Age
40 years Reference —
41-60 years 1.98 (1.24-3.16) .004
60 years 2.57 (1.57-4.20) .001
Body mass index
25 Reference —
25-40 1.04 (0.74-1.45) .836
40 1.85 (1.10-3.09) .019
Total operative time
60 minutes Reference —
60-120 minutes 1.12 (0.82-1.52) 0.494
120 minutes 1.68 (1.02-2.77) 0.043
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Background: Vena cava filter (VCF) use has been increasing in recent
years, particularly after the advent of retrievable filters. A significant number
of VCF appear to be utilized outside the defined indications for this
procedure. This so-called prophylactic VCF placement is particularly con-
troversial, as it is not supported by solid clinical data but is applied liberally in
“high-risk” patients (multiple trauma, morbid obesity). The aim of thisstudy was to investigate the current practice on VCF use at our own
institution.
Methods: Consecutive patients with VCF placement over a 2-year
period (2007 to 2009) at a university hospital were reviewed. Patient
demographics, filter type, retrieval, complications, indications for the pro-
cedure, and department performing the procedure were collected in all
patients.
Results: A total of 244 patients underwent VCF placement of which
159 were retrievable and 84 were permanent. Fifty-four percent of patients
had the VCF placed for an absolute indication, 14% for a relative indication,
and 32% for prophylaxis. Of those patients with a retrievable filter, only 14
(9%) had it removed. Eight patients had a complication of VCF placement,
while there were no complications of filter retrieval. Two of the eight
patients had a major complication: death and right ventricle injury. The
other six complications were considered minor, such as hematoma, filter
migration, and misdeployment. The Department of Trauma and Surgical
Critical Care (TSCC) placed the majority of VCF (n  107), followed by
Vascular Surgery (n  77) and Interventional Radiology (n  60). VCF
placement for prophylaxis alone without absolute indication was 57% from
the TSCC, 18.3% from Interventional Radiology (P  .0001), and 5.2%
from Vascular Surgery (P  .0001 compared with TSCC and P  .025
compared with Interventional Radiology).
Conclusions: The results of this study indicate that as many as 32% of
VCF placed are placed for prophylaxis. A very low percent of VCF is
retrieved. The majority of VCF at this university were placed by the TSCC.
These practices are not in accordance to strict evidence-based guidelines for
VCF placement. This is likely the practice at many other large US university-
based hospitals necessitating strategies for reducing their placement.
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Objective: To determine differences in venous disease across a spec-
trum of body mass index (BMI) from participants in the National Venous
Screening Program (NVSP).
Methods: Utilizing the prospectively maintained database from the
NVSP, statistical analysis was performed to examine differences between
participants according to standard BMI group designations. Data points for
comparison included demographics, thromboembolic (venous thromboem-
bolism) risk assessment, venous quality of life (CIVIQ2), duplex evaluation,
CEAP classification, and venous clinical severity score. A P value of less than
0.01 was considered statistically significant.
Results: From 2005 to 2010, the NVSP has screened 7227 Americans.
BMI category distribution included underweight (UW; BMI 18.5) 1.3%;
normal weight (NW; BMI 18.5-24.9) 34.9%; overweight (OW; BMI 25-
29.9) 34.9%; obese (OB; BMI 30-34.9) 16.6%; morbidly obese (MOB;
BMI 35-39.9) 7.8%; and super morbidly obese (SMOB; BMI 40) 4.7%.
Significant increases in BMI occurred incrementally in diabetes (NW: 4.9%
to SMOB: 25.2%) and hypertension (NW: 22.9% to SMOB: 54.3%). Mean
venous thromboembolism risk assessment scores significantly increased in-
crementally (NW: 3.32 to SMOB: 4.12). Mean quality-of-life scores signif-
icantly increased incrementally (NW: 20.3 to SMOB: 29.02). This observa-
tion was related to differences in limitations of activity. Mean CEAP scores
demonstrated significant incremental increases (NW: 1.49, OW: 1.54, OB:
1.64, MOB: 1.86, SMOB: 2.01). Mean venous clinical severity score scores
significantly increased incrementally (NW: 2.80 to SMOB: 4.58). Duplex
data demonstrated a significantly higher percentage of common femoral vein
reflux in the UW group compared with the overweight classes (UW: 26.04%
to SMOB: 18.69%).
Conclusions: Americans participating in the NVSP show worsening of
venous disease across most objective measures as BMI increases. The pres-
ence of common femoral vein reflux appears to be less with increasing BMI,
and brings in to question the appropriateness of this limited duplex exami-
nation in this population versus calf-muscle pump dysfunction. As obesity
rates climb at a rapid rate, the morbidity and mortality from venous disease
could markedly worsen. This information remains vital across all levels of
health care and further provides objective data to promote programs to
prevent obesity.
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